Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Operating activities    
Net loss $ (45,167,731) $ (42,253,426)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 236,864 216,635
Amortization of right-of-use assets 841,299 773,653
Stock-based compensation 5,137,068 3,517,128
Common stock issued for services 467,500 931,350
Foreign currency exchange loss (gain), net 144,085 (103,136)
Gain on extinguishment of debt (960,790)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 613,432 1,470,982
Other long-term assets 49,854 42,431
Accounts payable and accrued liabilities (2,561,215) 3,617,923
Accrued compensation related 35,528 (391,096)
Operating lease liabilities (629,928) (967,808)
Net cash used in operating activities (41,794,034) (33,145,364)
Investing activities    
Purchases of property and equipment (304,603)
Purchase of intangible assets (495,000)
Net cash used in investing activities (799,603)
Financing activities    
Proceeds from issuance of common stock through ESPP 9,973 7,012
Proceeds from issuance of common stock and/or warrants 57,004,412 30,000,000
Payment of financing and offering costs (4,434,441) (1,954,678)
Cash paid for stock options cancellation (25,819)
Cash paid for repurchase of warrants (178,225)
Proceeds from exercise of stock options 636,993
Proceeds from exercise of warrants 4,792,951
Purchase of shares under CGP and Sirtex stock purchase agreements 5,836,731
Proceeds from note payable 952,744
Principal payments on note payable (619,105) (138,244)
Tax withholdings paid on equity awards (238,976) (26,859)
Tax withholdings paid related to net share settlement of equity awards (263,100)
Tax shares sold to pay for tax withholdings on equity awards 220,490 26,495
Proceeds from co-promotion agreement 5,000,000
Net cash provided by financing activities 68,209,028 28,399,326
Effect of exchange rate changes on cash (18,620) (47,280)
Net increase (decrease) in cash and cash equivalents 25,596,771 (4,793,318)
Cash and cash equivalents, at beginning of year 20,354,462 25,147,780
Cash and cash equivalents, at end of year 45,951,233 20,354,462
Supplemental disclosure for cash flow information:    
Interest 10,302 3,179
Income taxes 4,992 2,450
Noncash investing and financing transactions:    
Expiration of warrants 329,099 2,465,396
Increase in right-of-use assets and operating lease liabilities resulting from contract modification 338,819 5,288,981
Note issued for insurance premium $ 1,355,919 $ 551,803